Literature DB >> 32418496

Gut Pathology and Its Rescue by ACE2 (Angiotensin-Converting Enzyme 2) in Hypoxia-Induced Pulmonary Hypertension.

Ravindra K Sharma1, Aline C Oliveira1, Tao Yang2, Marianthi M Karas1, Jing Li1, Gilberto O Lobaton1, Victor P Aquino1, Iñaki Robles-Vera3, Annette D de Kloet1, Eric G Krause4, Andrew J Bryant5, Amrisha Verma6, Qiuhong Li6, Elaine M Richards1, Mohan K Raizada1.   

Abstract

Therapeutic advances for pulmonary hypertension (PH) have been incremental because of the focus on the pulmonary vasculature in PH pathology. Here, we evaluate the concept that PH is, rather, a systemic disorder involving interplay among multiorgan systems, including brain, gut, and lungs. Therefore, the objective of this study was to evaluate the hypothesis that PH is associated with a dysfunctional brain-gut-lung axis and that global overexpression of ACE2 (angiotensin-converting enzyme 2) rebalances this axis and protects against PH. ACE2 knockin and wild-type (WT; C57BL/6) mice were subjected to chronic hypoxia (10% FIO2) or room air for 4 weeks. Cardiopulmonary hemodynamics, histology, immunohistochemistry, and fecal 16S rRNA microbial gene analyses were evaluated. Hypoxia significantly increased right ventricular systolic pressure, sympathetic activity as well as the number and activation of microglia in the paraventricular nucleus of the hypothalamus in WT mice. This was associated with a significant increase in muscularis layer thickening and decreases in both villi length and goblet cells and altered gut microbiota. Global overexpression of ACE2 prevented changes in hypoxia-induced pulmonary and gut pathophysiology and established distinct microbial communities from WT hypoxia mice. Furthermore, WT mice subjected to fecal matter transfer from ACE2 knockin mice were resistant to hypoxia-induced PH compared with their controls receiving WT fecal matter transfer. These observations demonstrate that ACE2 ameliorates these hypoxia-induced pathologies and attenuates PH. The data implicate dysfunctional brain-gut-lung communication in PH and provide novel avenues for therapeutic interventions.

Entities:  

Keywords:  angiotensin-converting enzyme 2; fecal matter transplantation; microbiota; microglia; pathology; pulmonary hypertension

Mesh:

Substances:

Year:  2020        PMID: 32418496      PMCID: PMC7505091          DOI: 10.1161/HYPERTENSIONAHA.120.14931

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  60 in total

1.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

Review 2.  A Paradigm Shift Is Needed in the Field of Pulmonary Arterial Hypertension for Its Entrance Into the Precision Medicine Era.

Authors:  Vikram Gurtu; Evangelos D Michelakis
Journal:  Circ Res       Date:  2016-12-09       Impact factor: 17.367

3.  Involvement of Microglial Cells in Hypoxia-induced Pulmonary Hypertension.

Authors:  Aline C Oliveira; Ravindra K Sharma; Victor Aquino; Gilberto Lobaton; Andrew J Bryant; Jeffrey K Harrison; Elaine M Richards; Mohan K Raizada
Journal:  Am J Respir Cell Mol Biol       Date:  2018-08       Impact factor: 6.914

4.  Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension.

Authors:  Ravindra K Sharma; Tao Yang; Aline C Oliveira; Gilberto O Lobaton; Victor Aquino; Seungbum Kim; Elaine M Richards; Carl J Pepine; Colin Sumners; Mohan K Raizada
Journal:  Circ Res       Date:  2019-03       Impact factor: 17.367

Review 5.  Pulmonary hypertension: Pathophysiology beyond the lung.

Authors:  Aline C Oliveira; Elaine M Richards; Mohan K Raizada
Journal:  Pharmacol Res       Date:  2019-11-13       Impact factor: 7.658

6.  Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus.

Authors:  In Koo Hwang; Ki-Yeon Yoo; Hua Li; Ok Kyu Park; Choong Hyun Lee; Jung Hoon Choi; Young-Gil Jeong; Yun Lyul Lee; Young-Myeong Kim; Young-Guen Kwon; Moo-Ho Won
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

7.  Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.

Authors:  Yan Fei Qi; Juan Zhang; Lei Wang; Vinayak Shenoy; Eric Krause; S Paul Oh; Carl J Pepine; Michael J Katovich; Mohan K Raizada
Journal:  J Mol Med (Berl)       Date:  2016-01       Impact factor: 4.599

8.  Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition.

Authors:  Haitao Xiong; Bingxiu Guo; Zhenshun Gan; Deguang Song; Zeqing Lu; Hongbo Yi; Yueming Wu; Yizhen Wang; Huahua Du
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

9.  Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome.

Authors:  María Callejo; Gema Mondejar-Parreño; Bianca Barreira; José L Izquierdo-Garcia; Daniel Morales-Cano; Sergio Esquivel-Ruiz; Laura Moreno; Ángel Cogolludo; Juan Duarte; Francisco Perez-Vizcaino
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

10.  Disordered microbial communities in asthmatic airways.

Authors:  Markus Hilty; Conor Burke; Helder Pedro; Paul Cardenas; Andy Bush; Cara Bossley; Jane Davies; Aaron Ervine; Len Poulter; Lior Pachter; Miriam F Moffatt; William O C Cookson
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more
  12 in total

1.  Effect of hepatocyte growth factor on mice with hypoxic pulmonary arterial hypertension: a preliminary study.

Authors:  Hu-Ting Tang; Wei-Hao Mu; Yu-Jing Xiang; Yong An
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

Review 2.  Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Kuldeep Dhama; Sang-Soo Lee
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 3.  Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?

Authors:  Ke-Xue Li; Zi-Chao Wang; Jeremiah Ong'Achwa Machuki; Meng-Zhen Li; Yu-Jie Wu; Ming-Kai Niu; Kang-Ying Yu; Qing-Bo Lu; Hai-Jian Sun
Journal:  Front Physiol       Date:  2022-04-01       Impact factor: 4.755

4.  Fecal matter transplant from Ace2 overexpressing mice counteracts chronic hypoxia-induced pulmonary hypertension.

Authors:  Aline C Oliveira; Tao Yang; Jing Li; Ravindra K Sharma; Marianthi K Karas; Andrew J Bryant; Annette D de Kloet; Eric G Krause; Bina Joe; Elaine M Richards; Mohan K Raizada
Journal:  Pulm Circ       Date:  2022-01-10       Impact factor: 2.886

Review 5.  ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.

Authors:  Ravindra K Sharma; Bruce R Stevens; Alexander G Obukhov; Maria B Grant; Gavin Y Oudit; Qiuhong Li; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Hypertension       Date:  2020-08-12       Impact factor: 10.190

6.  Tanreqing Injection Regulates Cell Function of Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cells (HPASMCs) through TRPC1/CX3CL1 Signaling Pathway.

Authors:  Yonghong Xiang; Fei Zheng; Qinzhe Zhang; RunJuan Zhang; Haiyan Pan; Zongdong Pang; Shimin Dai; Yurong Zhang; Ye Wu; Lunkai Yao; Mengju Su; Luying Lan
Journal:  Oxid Med Cell Longev       Date:  2022-02-11       Impact factor: 6.543

7.  Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan.

Authors:  Yumiko Ikubo; Takayuki Jujo Sanada; Koji Hosomi; Jonguk Park; Akira Naito; Hiroki Shoji; Tomoko Misawa; Rika Suda; Ayumi Sekine; Toshihiko Sugiura; Ayako Shigeta; Hinako Nanri; Seiichiro Sakao; Nobuhiro Tanabe; Kenji Mizuguchi; Jun Kunisawa; Takuji Suzuki; Koichiro Tatsumi
Journal:  BMC Pulm Med       Date:  2022-04-08       Impact factor: 3.317

Review 8.  A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency.

Authors:  Elizabeth M Sajdel-Sulkowska
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

9.  Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat.

Authors:  Wen-Jie Xia; Meng-Lu Xu; Xiao-Jing Yu; Meng-Meng Du; Xu-Hui Li; Tao Yang; Lu Li; Ying Li; Kai B Kang; Qing Su; Jia-Xi Xu; Xiao-Lian Shi; Xiao-Min Wang; Hong-Bao Li; Yu-Ming Kang
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Gut Microbiota-Derived PGF2α Fights against Radiation-Induced Lung Toxicity through the MAPK/NF-κB Pathway.

Authors:  Zhi-Yuan Chen; Hui-Wen Xiao; Jia-Li Dong; Yuan Li; Bin Wang; Sai-Jun Fan; Ming Cui
Journal:  Antioxidants (Basel)       Date:  2021-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.